Double-Masked, Placebo-Controlled Study of Intravenous Levetiracetam for the Treatment of Status Epilepticus and Acute Repetitive Seizures in Dogs

Journal of Veterinary Internal Medicine

Volumn 26, Issue 2, 2012, Pages 334-340

  Hardy, B T ^a   Patterson, E E ^a   Cloyd, J M ^a   Hardy, R M ^a   Leppik, I E ^a,b,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c MINCEP Epilepsy Care   (United States)

Author keywords

Canine; Cluster seizures; Epilepsy; Pharmacokinetics

Indexed keywords

ANTICONVULSIVE AGENT; DIAZEPAM; DRUG DERIVATIVE; ETIRACETAM; PIRACETAM;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOG; DOG DISEASE; DOUBLE BLIND PROCEDURE; EPILEPTIC STATE; FEMALE; HALF LIFE TIME; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONPARAMETRIC TEST; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SEIZURE;

ANIMALS; ANTICONVULSANTS; DIAZEPAM; DOG DISEASES; DOGS; DOUBLE-BLIND METHOD; FEMALE; HALF-LIFE; INJECTIONS, INTRAVENOUS; MALE; PILOT PROJECTS; PIRACETAM; SEIZURES; STATISTICS, NONPARAMETRIC; STATUS EPILEPTICUS;

ANIMALIA; CANIS FAMILIARIS;

EID: 84858747815     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2011.00868.x     Document Type: Article

References (32)

1. Platt SR, Haag M. Canine status epilepticus: A retrospective study of 50 cases. J Small Anim Pract 2002;43:151-153.
2. Saito M, Munana KR, Sharp NJ, et al. Risk factors for development of status epilepticus in dogs with idiopathic epilepsy and effects of status epilepticus on outcome and survival time: 32 cases (1990-1996). J Am Vet Med Assoc 2001;219:618-623.
3. Bleck TP. Management approaches to prolonged seizures and status epilepticus. Epilepsia 1999;40:s59-s63.
4. Gilad R, Izkovitz N, Dabby R, et al. Treatment of status epilepticus and acute repetitive seizures with i.v. valproic acid vs phenytoin. Acta Neurol Scand 2008;118:296-300.
5. Beran RG. An alternative perspective on the management of status epilepticus. Epilepsy Behav 2008;12:349-353.
6. Bateman SW, Parent JM. Clinical findings, treatment, and outcome of dogs with status epilepticus or cluster seizures: 156 cases (1990-1995). J Am Vet Med Assoc 1999;215:1463-1468.
7. Zimmermann R, Hulsmeyer VI, Sauter-Louis C, et al. Status epilepticus and epileptic seizures in dogs. J Vet Intern Med 2009;23:970-976.
8. Chin RF, Neville BG, Scott RC. A systematic review of the epidemiology of status epilepticus. Eur J Neurol 2004;11:800-810.
9. DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996;46:1029-1035.
10. Leppik IE, Derivan AT, Homan RW, et al. Double-blind study of lorazepam and diazepam in status epilepticus. J Am Med Assoc 1983;249:1452-1454.
11. Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Eng J Med 2001;345:631-637.
12. Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Eng J Med 1998;339:792-798.
13. Alvarez V, Januel J-M, Burnand B, et al. Second-line status epilepticus treatment: Comparison of phenytoin, valproate, and levetiracetam. Epilepsia 2011;52:1292-1296.
14. Fattouch J, Di Bonaventura C, Casciato S, et al. Intravenous levetiracetam as first-line treatment of status epilepticus in the elderly. Acta Neurol Scand 2010;121:418-421.
15. Xu T, Bajjalieh SM. SV2 modulates the size of the readily releasable pool of secretory vesicles. Nat Cell Biol 2001;3:691-698.
16. Lynch BA, Lambeng N, Nocka K, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 2004;101:9861-9866.
17. De Smedt T, Raedt R, Vonck K, et al. Levetiracetam: Part II, the clinical profile of a novel anticonvulsant drug. CNS Drug Rev 2007;13:57-78.
18. Patterson EE, Goel V, Cloyd JC, et al. Intramuscular, intravenous and oral levetiracetam in dogs: Safety and pharmacokinetics. J Vet Pharmacol Ther 2008;31:253-258.
19. Dewey CW, Bailey KS, Boothe DM, et al. Pharmacokinetics of single-dose intravenous levetiracetam administration in normal dogs. J Vet Emerg Crit Care 2008;18:153-157.
20. Doheny HC, Ratnaraj N, Whittington MA, et al. Blood and cerebrospinal fluid pharmacokinetics of the novel anticonvulsant levetiracetam (ucb L059) in the rat. Epilepsy Res 1999;34:161-168.
21. Tong X, Patsalos PN. A microdialysis study of the novel antiepileptic drug levetiracetam: Extracellular pharmacokinetics and effect on taurine in rat brain. Br J Pharmacol 2001;133:867-874.
22. Thomas W. Idiopathic epilepsy in dogs and cats. Vet Clin North Am Small Anim Pract 2010;40:161-179.
23. Patsalos PN. Pharmacokinetic profile of levetiracetam: Toward ideal characteristics. Pharmacol Ther 2000;85:77-85.
24. Bazil CW. New antiepileptic drugs. Neurologist 2002;8:71-81.
25. Moore SA, Munana KR, Papich MG, et al. The pharmacokinetics of levetiracetam in healthy dogs concurrently receiving phenobarbital. J Vet Pharmacol Ther 2011;34:31-34.
26. Indrieri RJ. Status epilepticus. Probl Vet Med 1989;1:606-618.
27. Serrano S, Hughes D, Chandler K. Use of ketamine for the management of refractory status epilepticus in a dog. J Vet Intern Med 2006;20:194-197.
28. Vernau KM, LeCouteur RA. Seizures and status epilepzticus. In: Silverstein DC, Hopper K, eds. Small Animal Critical Care Medicine. Saint Louis, MO: Saunders Elsevier; 2009:414-419.
29. Steffen F, Grasmueck S. Propofol for treatment of refractory seizures in dogs and a cat with intracranial disorders. J Small Anim Pract 2000;41:496-499.
30. Cranford RE, Leppik IE, Patrick B, et al. Intravenous phenytoin in acute treatment of seizures. Neurology 1979;29:1474-1479.
31. Leppik IE, Patterson E, Hardy B, et al. Canine status epilepticus: Proof of principle studies. Epilepsia 2009;50(Suppl 12):14-15.
32. DeLorenzo RJ, Waterhouse EJ, Towne AR, et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia 1998;39:833-840.